Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year?
Published on: July 2, 2026, 6:42 a.m. | Source: The Indian Express
A caffeine giant, a growing CDMO business, and a recovering API segment. Can Aarti Pharmalabs convert a Rs 1,300+ crore capex cycle into a compounding pharma platform?
